Banerjee R, Liu M, Bellile E, Schmitd LB, Goto M, Hutchinson MND, Singh P, Zhang S, Damodaran DPV, Nyati MK, Spector ME, Ward B, Wolf G, Casper K, Mierzwa M, D'Silva NJ. Phosphorylation of TRIP13 at Y56 induces radiation resistance but sensitizes head and neck cancer to cetuximab. Mol Ther. 2022 01 05; 30(1):468-484.